The ingredient, explained
Potassium Hydroxide
A randomized clinical trial tested this exact ingredient as a medical treatment.
Ingredient guide
What it is and what it does
Potassium hydroxide
About this ingredient: EU CosIng ingredient registry (via Open Beauty Facts taxonomy) ↗
- Buffering
- Helps resist changes in a formula's pH.
Function definitions: European Commission ingredient function definitions (SCCNFP/0299/00, pages 16 to 20) ↗
Registry functions describe possible formulation roles, not results for a finished product. A dictionary entry is not an approval or a safety assessment.
A closer look
What the research shows
Human topical treatment study
Both arms reduced lesions by week 12; the trial did not establish superior efficacy of potassium hydroxide.
What this does not tell us
Medical caustic wart treatment differs from low-concentration cosmetic pH adjustment. Open-label active-comparator study, no vehicle.
Sources for this summary. PubMed 25039244 ↗
Research review checked Oct 1, 2026
Bounded review of local candidates, exact-name indexed primary journal/PubMed safety and topical searches; not a systematic review.
Ingredient research is not proof that a product containing this ingredient works.
Read the 1 selected study
Human topical treatment study · n=60
A comparison of a 5% potassium hydroxide solution with a 5-fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open-label clinical trial. ↗
International journal of dermatology · 2014
Follow the formula
Products containing this ingredient
From the wider catalogue. Linked by the ingredient list, without an efficacy ranking.
Names and identifiers
Registry identity
Potassium hydroxide
- INCI name on ingredient lists
- POTASSIUM HYDROXIDE
- CAS registry number
- 1310-58-3
- EC number
- 215-181-3
Other recorded names (1)
- kalii hydroxidum
Sources for this ingredient record
- EU CosIng ingredient registry (via Open Beauty Facts taxonomy) ↗ · ODbL 1.0 (Open Beauty Facts database) · Recorded Aug 8, 2026


